Marksans Pharma, 524404, MARKSANS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

13,982.37
40.34
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,349.77
0.19%
6.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.58
13.93
13.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.06
18.99
12.11

PAT CAGR (%)

10 Years
5 Years
3 Years

11.11
21.80
19.34

P:E (Median)

8 Years
5 Years
3 Years

15.46
13.83
15.76

P:BV (Average)

8 Years
5 Years
3 Years

2.79
2.75
2.84

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.63
9.25
10.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 308.63 204.67 50.79% 254.53 182.04 39.82% 225.20 153.05 47.14% 241.36 172.75 39.72%
Expenses 256.35 167.37 53.16% 213.26 155.28 37.34% 191.29 130.34 46.76% 199.39 148.93 33.88%
EBITDA 52.27 37.30 40.13% 41.27 26.76 54.22% 33.91 22.71 49.32% 41.97 23.82 76.20%
EBIDTM 16.94% 18.22% 16.21% 14.70% 15.06% 14.84% 17.39% 13.79%
Other Income 31.36 15.93 96.86% 8.15 32.62 -75.02% 12.19 4.30 183.49% 1.32 15.71 -91.60%
Interest 0.28 0.23 21.74% 0.28 0.26 7.69% 0.23 0.66 -65.15% 0.27 0.85 -68.24%
Depreciation 7.02 8.50 -17.41% 6.84 4.72 44.92% 7.47 3.51 112.82% 8.43 4.18 101.67%
PBT 76.34 44.50 71.55% 42.30 54.40 -22.24% 38.40 22.84 68.13% 34.60 34.50 0.29%
Tax 13.13 13.21 -0.61% 10.28 10.20 0.78% 5.40 5.04 7.14% 9.31 8.88 4.84%
PAT 63.20 31.29 101.98% 32.02 44.19 -27.54% 32.99 17.81 85.23% 25.29 25.62 -1.29%
PATM 20.48% 15.29% 12.58% 24.28% 14.65% 11.64% 10.48% 14.83%
EPS 1.39 0.69 101.45% 0.71 0.98 -27.55% 0.73 0.39 87.18% 0.56 0.57 -1.75%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 641.92 531.24 20.83% 590.62 500.03 18.12% 560.01 485.98 15.23% 586.13 479.83 22.15%
Expenses 506.24 417.29 21.32% 462.18 398.07 16.11% 450.37 376.43 19.64% 453.11 403.19 12.38%
EBITDA 135.68 113.95 19.07% 128.44 101.97 25.96% 109.64 109.55 0.08% 133.02 76.64 73.56%
EBIDTM 21.14% 21.45% 21.75% 20.39% 19.58% 22.54% 22.70% 15.97%
Other Income 11.06 19.00 -41.79% 14.95 10.10 48.02% 16.53 11.01 50.14% 4.80 17.65 -72.80%
Interest 2.63 1.63 61.35% 2.92 1.58 84.81% 4.84 2.44 98.36% 3.16 2.35 34.47%
Depreciation 19.51 17.55 11.17% 20.44 13.66 49.63% 21.05 13.94 51.00% 22.00 12.74 72.68%
PBT 124.60 113.77 9.52% 120.02 96.83 23.95% 100.28 104.17 -3.73% 112.66 79.20 42.25%
Tax 26.84 29.92 -10.29% 30.95 26.39 17.28% 22.63 21.46 5.45% 29.69 16.90 75.68%
PAT 97.76 83.85 16.59% 89.07 70.44 26.45% 77.64 82.71 -6.13% 82.97 62.31 33.16%
PATM 15.23% 15.78% 15.08% 14.09% 13.86% 17.02% 14.15% 12.98%
EPS 2.13 1.84 15.76% 1.96 1.52 28.95% 1.73 1.81 -4.42% 1.84 1.57 17.20%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,029.72 853.27 655.20 658.29 599.55 433.42 424.16 294.66 215.84 358.13 405.59 Net Sales Growth 44.52% 30.23% -0.47% 9.80% 38.33% 2.18% 43.95% 36.52% -39.73% -11.70% Cost Of Goods Sold 566.01 478.93 394.44 377.59 337.91 245.41 236.34 169.35 112.37 178.18 218.16 Gross Profit 463.71 374.34 260.75 280.70 261.63 188.00 187.82 125.31 103.47 179.95 187.44 GP Margin 45.03% 43.87% 39.80% 42.64% 43.64% 43.38% 44.28% 42.53% 47.94% 50.25% 46.21% Total Expenditure 860.29 713.34 582.23 544.57 485.84 361.93 360.83 265.52 202.15 258.76 299.58 Power & Fuel Cost - 26.04 14.24 11.49 10.90 8.95 8.44 7.26 7.21 7.55 7.74 % Of Sales - 3.05% 2.17% 1.75% 1.82% 2.06% 1.99% 2.46% 3.34% 2.11% 1.91% Employee Cost - 77.19 56.09 60.46 54.64 48.51 46.33 45.86 39.77 26.13 23.65 % Of Sales - 9.05% 8.56% 9.18% 9.11% 11.19% 10.92% 15.56% 18.43% 7.30% 5.83% Manufacturing Exp. - 49.96 26.22 5.25 56.39 32.15 12.69 11.52 11.99 13.99 15.42 % Of Sales - 5.86% 4.00% 0.80% 9.41% 7.42% 2.99% 3.91% 5.56% 3.91% 3.80% General & Admin Exp. - 26.86 21.36 16.58 14.79 16.19 22.68 10.95 10.61 9.42 7.50 % Of Sales - 3.15% 3.26% 2.52% 2.47% 3.74% 5.35% 3.72% 4.92% 2.63% 1.85% Selling & Distn. Exp. - 45.79 53.97 59.37 8.56 10.37 34.30 20.58 20.20 23.48 21.52 % Of Sales - 5.37% 8.24% 9.02% 1.43% 2.39% 8.09% 6.98% 9.36% 6.56% 5.31% Miscellaneous Exp. - 8.56 15.89 13.84 2.64 0.34 0.04 0.00 0.00 0.00 21.52 % Of Sales - 1.00% 2.43% 2.10% 0.44% 0.08% 0.01% 0% 0% 0% 1.38% EBITDA 169.42 139.93 72.97 113.72 113.71 71.49 63.33 29.14 13.69 99.37 106.01 EBITDA Margin 16.45% 16.40% 11.14% 17.28% 18.97% 16.49% 14.93% 9.89% 6.34% 27.75% 26.14% Other Income 53.02 62.07 79.41 42.25 31.16 0.17 7.93 7.43 17.75 13.21 12.82 Interest 1.06 0.99 3.61 3.80 5.34 7.29 6.56 7.67 4.49 6.20 13.11 Depreciation 29.76 29.13 16.74 17.66 15.19 11.64 8.69 12.25 15.00 14.75 9.03 PBT 191.64 171.89 132.03 134.51 124.33 52.73 56.01 16.65 11.95 91.63 96.69 Tax 38.12 38.13 29.17 30.52 25.95 14.82 12.39 4.23 0.40 20.14 29.58 Tax Rate 19.89% 22.18% 22.09% 22.69% 20.87% 28.11% 22.12% 25.41% 3.35% 21.98% 30.59% PAT 153.50 133.76 102.87 103.99 98.38 37.90 43.62 12.43 11.55 71.49 67.11 PAT before Minority Interest 153.50 133.76 102.87 103.99 98.38 37.90 43.62 12.43 11.55 71.49 67.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.91% 15.68% 15.70% 15.80% 16.41% 8.74% 10.28% 4.22% 5.35% 19.96% 16.55% PAT Growth 29.09% 30.03% -1.08% 5.70% 159.58% -13.11% 250.93% 7.62% -83.84% 6.53% EPS 3.39 2.95 2.27 2.29 2.17 0.84 0.96 0.27 0.25 1.58 1.48

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,378.68 2,177.41 1,852.14 1,490.84 1,376.18 1,134.21 1,000.07 912.69 767.16 893.33 796.69 Net Sales Growth 19.11% 17.56% 24.23% 8.33% 21.33% 13.41% 9.57% 18.97% -14.12% 12.13% Cost Of Goods Sold 1,062.82 1,038.12 921.36 716.81 595.05 567.83 498.01 523.13 458.74 509.69 445.44 Gross Profit 1,315.86 1,139.29 930.78 774.02 781.13 566.38 502.07 389.57 308.42 383.63 351.25 GP Margin 55.32% 52.32% 50.25% 51.92% 56.76% 49.94% 50.20% 42.68% 40.20% 42.94% 44.09% Total Expenditure 1,871.90 1,718.83 1,512.82 1,231.96 1,036.58 941.96 867.92 834.31 734.24 760.91 620.86 Power & Fuel Cost - 36.94 24.50 18.59 16.42 14.38 14.34 11.83 13.27 12.58 9.72 % Of Sales - 1.70% 1.32% 1.25% 1.19% 1.27% 1.43% 1.30% 1.73% 1.41% 1.22% Employee Cost - 293.64 239.37 220.30 197.32 168.42 159.07 147.75 149.70 122.42 72.61 % Of Sales - 13.49% 12.92% 14.78% 14.34% 14.85% 15.91% 16.19% 19.51% 13.70% 9.11% Manufacturing Exp. - 136.67 96.47 12.73 127.47 113.32 77.14 59.90 47.34 50.44 37.59 % Of Sales - 6.28% 5.21% 0.85% 9.26% 9.99% 7.71% 6.56% 6.17% 5.65% 4.72% General & Admin Exp. - 59.73 52.79 37.74 50.67 45.52 51.03 42.51 37.52 36.01 15.35 % Of Sales - 2.74% 2.85% 2.53% 3.68% 4.01% 5.10% 4.66% 4.89% 4.03% 1.93% Selling & Distn. Exp. - 127.31 133.19 119.05 33.54 32.15 68.36 49.14 27.66 29.77 34.47 % Of Sales - 5.85% 7.19% 7.99% 2.44% 2.83% 6.84% 5.38% 3.61% 3.33% 4.33% Miscellaneous Exp. - 26.42 45.14 106.73 16.10 0.34 -0.01 0.05 0.00 0.00 34.47 % Of Sales - 1.21% 2.44% 7.16% 1.17% 0.03% 0.00% 0.01% 0% 0% 0.71% EBITDA 506.78 458.58 339.32 258.88 339.60 192.25 132.15 78.38 32.92 132.42 175.83 EBITDA Margin 21.31% 21.06% 18.32% 17.36% 24.68% 16.95% 13.21% 8.59% 4.29% 14.82% 22.07% Other Income 47.34 50.42 59.31 41.85 6.69 0.33 4.62 8.47 18.85 12.72 12.23 Interest 13.55 11.20 9.13 8.45 7.99 8.75 9.66 10.22 6.78 10.16 16.05 Depreciation 83.00 74.27 51.85 44.78 36.15 26.66 22.80 26.84 30.09 28.13 16.13 PBT 457.56 423.53 337.65 247.51 302.16 157.17 104.31 49.80 14.90 106.85 155.88 Tax 110.11 108.63 72.33 60.70 63.63 36.42 23.87 14.00 3.56 24.11 43.92 Tax Rate 24.06% 25.65% 21.42% 24.52% 21.06% 23.17% 22.88% 28.11% 23.89% 22.56% 28.18% PAT 347.44 313.69 266.31 184.56 235.94 117.02 76.46 32.94 8.83 78.51 109.39 PAT before Minority Interest 347.00 314.89 265.32 186.81 238.54 120.75 80.44 35.80 11.33 82.74 111.96 Minority Interest -0.44 -1.20 0.99 -2.25 -2.60 -3.73 -3.98 -2.86 -2.50 -4.23 -2.57 PAT Margin 14.61% 14.41% 14.38% 12.38% 17.14% 10.32% 7.65% 3.61% 1.15% 8.79% 13.73% PAT Growth 16.08% 17.79% 44.29% -21.78% 101.62% 53.05% 132.12% 273.05% -88.75% -28.23% EPS 7.67 6.92 5.88 4.07 5.21 2.58 1.69 0.73 0.19 1.73 2.41

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,222.70 1,111.32 784.67 599.72 505.63 470.57 428.97 418.88 422.70 358.18 Share Capital 45.32 45.32 40.93 40.93 40.93 40.93 40.93 40.93 53.43 53.43 Total Reserves 1,177.39 1,066.01 650.64 558.79 464.69 429.64 388.04 377.95 369.27 304.75 Non-Current Liabilities 20.89 17.00 14.41 23.93 24.79 18.39 17.09 17.30 0.31 0.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.47 3.18 1.86 2.11 1.47 1.36 1.08 0.96 0.00 0.00 Current Liabilities 304.73 240.91 190.39 137.26 79.73 133.39 111.22 109.59 111.19 168.43 Trade Payables 159.72 111.58 74.45 64.16 56.65 37.23 33.68 20.60 31.41 44.58 Other Current Liabilities 105.84 97.65 78.95 42.70 10.92 7.34 8.79 0.71 0.68 39.88 Short Term Borrowings 0.00 0.00 5.00 0.00 0.00 77.33 66.31 73.23 40.62 43.52 Short Term Provisions 39.16 31.68 31.99 30.40 12.15 11.50 2.45 15.04 38.49 40.45 Total Liabilities 1,548.32 1,369.23 989.47 760.91 610.15 622.35 557.28 545.77 534.20 527.11 Net Block 271.57 143.94 135.51 129.09 115.18 102.61 87.89 93.92 97.47 90.01 Gross Block 472.78 318.89 301.34 277.25 248.77 224.90 201.83 195.61 184.48 162.47 Accumulated Depreciation 201.20 174.95 165.83 148.16 133.59 122.28 113.94 101.69 87.01 72.45 Non Current Assets 568.33 431.10 375.75 369.32 355.73 339.98 324.78 329.16 330.16 158.45 Capital Work in Progress 0.00 3.90 0.00 0.00 0.00 0.00 0.00 0.36 0.00 0.00 Non Current Investment 265.75 265.75 236.07 236.07 236.07 236.07 236.07 234.29 231.44 67.62 Long Term Loans & Adv. 30.84 17.50 4.16 4.16 4.47 1.29 0.82 0.59 1.25 0.83 Other Non Current Assets 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 979.99 938.13 613.73 391.60 254.41 282.37 232.51 216.61 204.04 368.66 Current Investments 26.99 0.54 0.44 0.26 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 190.85 130.95 103.67 93.69 74.60 70.36 42.29 29.24 43.74 51.03 Sundry Debtors 370.17 305.49 246.78 168.93 161.87 177.83 168.87 154.80 133.41 124.63 Cash & Bank 312.23 440.26 224.05 105.61 3.35 1.80 0.71 2.56 3.13 167.54 Other Current Assets 79.74 7.17 12.06 1.91 14.58 32.38 20.62 30.01 23.76 25.46 Short Term Loans & Adv. 68.00 53.71 26.73 21.20 13.76 24.91 14.54 29.92 23.76 25.46 Net Current Assets 675.27 697.22 423.34 254.34 174.68 148.98 121.28 107.02 92.85 200.23 Total Assets 1,548.32 1,369.23 989.48 760.92 610.14 622.35 557.29 545.77 534.20 527.11

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,065.05 1,745.16 1,202.27 886.50 636.01 542.48 470.86 433.43 454.32 379.76 Share Capital 45.32 45.32 40.93 40.93 40.93 40.93 40.93 40.93 53.43 53.43 Total Reserves 2,019.74 1,699.85 1,068.24 845.56 595.08 501.55 429.93 392.50 400.89 326.33 Non-Current Liabilities 205.20 84.33 57.05 23.70 24.15 17.14 15.64 16.07 -1.91 1.46 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.56 3.25 1.86 2.11 1.47 1.36 1.08 0.96 0.00 0.00 Current Liabilities 389.85 340.99 380.08 298.97 228.75 232.62 234.68 296.06 259.43 286.24 Trade Payables 268.28 230.60 200.08 168.66 110.33 106.07 77.83 161.78 118.98 107.02 Other Current Liabilities 70.62 42.20 96.80 79.69 58.86 20.90 10.08 0.71 0.68 39.88 Short Term Borrowings 29.09 41.59 41.29 18.74 18.84 99.91 117.41 109.71 87.89 82.19 Short Term Provisions 21.86 26.60 41.92 31.88 40.72 5.74 29.36 23.85 51.88 57.15 Total Liabilities 2,680.95 2,190.39 1,660.10 1,228.03 902.02 802.46 730.73 751.81 720.20 675.56 Net Block 775.94 486.31 428.31 309.36 302.72 269.73 279.38 266.98 269.65 165.90 Gross Block 1,193.49 828.26 726.26 551.92 565.39 506.26 495.35 456.49 429.47 297.78 Accumulated Depreciation 417.55 341.95 297.96 242.56 262.67 236.54 215.97 189.52 159.82 131.89 Non Current Assets 818.46 515.09 435.04 325.20 308.45 271.02 280.19 267.92 280.06 166.72 Capital Work in Progress 9.42 9.87 2.57 11.68 0.00 0.00 0.00 0.36 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 32.94 18.91 4.16 4.16 5.73 1.29 0.82 0.59 10.41 0.83 Other Non Current Assets 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,862.49 1,675.30 1,225.07 902.82 593.59 531.44 450.54 483.88 440.15 508.83 Current Investments 26.99 0.54 0.44 0.26 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 617.94 484.74 424.44 404.32 241.84 293.25 218.12 190.09 167.79 130.11 Sundry Debtors 453.18 416.85 394.78 271.95 243.35 176.60 176.91 247.58 217.29 183.45 Cash & Bank 673.58 714.96 349.26 212.18 93.73 33.54 39.88 25.16 35.30 185.27 Other Current Assets 90.80 22.74 24.36 14.11 14.66 28.06 15.63 21.05 19.76 10.01 Short Term Loans & Adv. 59.82 35.48 31.79 0.00 3.40 0.00 0.00 20.96 19.76 10.01 Net Current Assets 1,472.64 1,334.31 844.98 603.85 364.83 298.82 215.86 187.82 180.71 222.60 Total Assets 2,680.95 2,190.39 1,660.11 1,228.02 902.04 802.46 730.73 751.80 720.21 675.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 34.05 51.73 55.97 106.92 107.58 19.81 15.63 -13.62 64.76 112.03 PBT 171.89 132.03 134.51 124.33 52.73 56.01 16.65 11.95 91.63 96.69 Adjustment -16.40 10.91 -7.93 -8.82 19.17 11.57 20.00 12.50 8.82 17.75 Changes in Working Capital -82.68 -59.60 -38.77 11.62 46.17 -34.91 -16.33 -22.39 -15.35 28.53 Cash after chg. in Working capital 72.82 83.34 87.80 127.13 118.06 32.67 20.32 2.06 85.09 142.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -38.76 -31.62 -31.83 -20.21 -10.49 -12.86 -4.68 -15.69 -20.33 -30.94 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -114.22 -194.62 -128.06 8.87 -24.15 -20.20 -7.55 -7.69 -177.34 -29.14 Net Fixed Assets -149.99 -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 -22.01 -32.23 Net Investments -26.45 -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 -163.82 0.00 Others 62.22 -143.39 -103.79 37.61 -0.28 2.87 0.09 6.65 8.49 3.09 Cash from Financing Activity -26.21 210.02 70.86 -13.53 -81.87 0.96 -9.98 20.74 -51.83 51.28 Net Cash Inflow / Outflow -106.38 67.12 -1.23 102.26 1.55 0.56 -1.90 -0.57 -164.41 134.17 Opening Cash & Equivalents 148.31 81.19 82.42 3.35 1.80 0.55 2.45 3.13 167.54 33.37 Closing Cash & Equivalent 41.93 148.31 81.19 105.61 3.35 1.12 0.55 2.56 3.13 167.54

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 230.41 237.41 99.26 178.59 233.33 27.40 50.09 14.06 30.80 154.51 PBT 423.53 337.65 247.51 302.16 157.17 104.31 49.80 14.90 106.85 109.40 Adjustment 55.42 74.24 35.31 56.57 42.04 31.88 43.99 26.58 39.63 24.26 Changes in Working Capital -126.19 -111.47 -110.70 -131.61 59.12 -81.79 -36.23 -6.04 -88.14 20.27 Cash after chg. in Working capital 352.76 300.43 172.12 227.12 258.33 54.40 57.56 35.44 58.34 153.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -122.35 -63.01 -72.86 -48.53 -25.00 -27.00 -7.46 -21.37 -27.54 -0.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -140.84 -259.21 -84.39 -44.85 -59.58 -13.48 -38.81 -20.73 -123.01 -33.19 Net Fixed Assets -149.99 -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 -22.01 -32.23 Net Investments -26.45 -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 -163.82 0.00 Others 35.60 -207.98 -60.12 -16.11 -35.71 9.59 -31.17 -6.39 62.82 -0.96 Cash from Financing Activity -68.73 197.83 79.51 -15.29 -113.55 -20.78 3.38 -3.47 -57.75 16.99 Net Cash Inflow / Outflow 20.84 176.03 94.38 118.46 60.19 -6.86 14.67 -10.14 -149.96 138.32 Opening Cash & Equivalents 382.44 206.41 112.03 93.73 33.54 39.72 25.05 35.30 185.27 46.95 Closing Cash & Equivalent 403.28 382.44 206.41 212.18 93.73 32.85 39.72 25.16 35.30 185.27

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 26.98 24.52 16.90 14.65 12.35 11.50 10.48 10.23 10.02 8.45 ROA 9.17% 8.72% 11.88% 14.35% 6.15% 7.40% 2.25% 2.14% 13.47% 14.85% ROE 11.46% 11.41% 16.11% 17.80% 7.77% 9.70% 2.93% 2.79% 18.91% 27.27% ROCE 14.81% 14.27% 19.91% 23.46% 11.39% 11.99% 4.92% 3.44% 22.45% 33.41% Fixed Asset Turnover 2.16 2.24 2.30 2.30 1.83 1.99 1.48 1.14 2.06 2.77 Receivable days 144.13 144.90 114.03 99.91 143.04 149.17 200.47 243.69 131.50 106.64 Inventory Days 68.65 61.56 54.14 50.83 61.04 48.47 44.31 61.71 48.29 47.98 Payable days 103.38 86.07 66.99 65.25 47.33 37.28 36.94 45.72 53.08 52.33 Cash Conversion Cycle 109.41 120.38 101.18 85.49 156.75 160.37 207.84 259.68 126.70 102.30 Total Debt/Equity 0.00 0.00 0.01 0.00 0.00 0.17 0.16 0.17 0.10 0.14 Interest Cover 174.98 37.54 36.44 24.26 8.23 9.54 3.17 3.66 15.77 8.37

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 45.57 38.51 27.10 21.66 15.54 13.25 11.50 10.59 10.79 8.97 ROA 12.93% 13.78% 12.94% 22.40% 14.17% 10.49% 4.83% 1.54% 11.86% 19.21% ROE 16.53% 18.59% 18.72% 31.33% 20.49% 15.88% 7.92% 2.59% 20.45% 45.15% ROCE 22.40% 22.89% 23.82% 39.76% 25.57% 18.51% 10.60% 3.99% 23.16% 44.64% Fixed Asset Turnover 2.26 2.62 2.42 2.49 2.12 2.00 1.92 1.73 2.46 2.85 Receivable days 69.35 72.63 78.56 67.57 67.57 64.51 84.88 110.59 81.87 80.88 Inventory Days 87.89 81.36 97.65 84.73 86.10 93.32 81.63 85.14 60.86 53.30 Payable days 87.70 85.31 93.88 85.57 45.09 38.48 55.10 65.56 54.58 56.06 Cash Conversion Cycle 69.54 68.67 82.33 66.73 108.58 119.35 111.40 130.17 88.15 78.13 Total Debt/Equity 0.01 0.02 0.04 0.02 0.03 0.18 0.25 0.25 0.19 0.23 Interest Cover 38.80 37.99 30.31 38.84 18.97 11.80 5.87 3.20 11.52 10.72

Top Investors:

orbimed asia iv mauritius fvci limited

massachusetts institute of technology

uti small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Marksans Pharma gets USFDA’s final approval for Loratadine Tablets
23rd Nov 2024, 14:47 PM

This product is generic version of Clartin tablet in the same strength of Bayer Healthcare
Read More
Marksans Pharma’s arm secures marketing authorization for three products
21st Aug 2024, 12:11 PM

These products are Fluoxetine 10mg Capsules, Fluoxetine 30mg Capsules and Fluoxetine 60mg Capsules
Read More
USFDA issues EIR for Marksans Pharma’s Goa manufacturing facility
20th Aug 2024, 15:59 PM

USFDA has determined that the inspection classification of this facility is Voluntary Action Indicated
Read More

Marksans Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524404 | NSE: MARKSANS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Marksans Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524404 | NSE: MARKSANS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: